Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective
The melanocortin-4 receptor (MC4R) can be endogenously activated by binding of melanocyte-stimulating hormones (MSH), which mediates anorexigenic effects. In contrast, the agouti-related peptide (AgRP) acts as an endogenous inverse agonist and suppresses ligand-independent basal signaling activity (...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00515/full |
id |
doaj-c6f24ae870f145b8a2c9a641fa877eeb |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nicolas Heyder Gunnar Kleinau Michal Szczepek Dennis Kwiatkowski David Speck Lucia Soletto José Miguel Cerdá-Reverter Heiko Krude Peter Kühnen Heike Biebermann Patrick Scheerer |
spellingShingle |
Nicolas Heyder Gunnar Kleinau Michal Szczepek Dennis Kwiatkowski David Speck Lucia Soletto José Miguel Cerdá-Reverter Heiko Krude Peter Kühnen Heike Biebermann Patrick Scheerer Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective Frontiers in Endocrinology G-protein coupled receptor melanocortin receptors MC4R MSH AgRP ACTH |
author_facet |
Nicolas Heyder Gunnar Kleinau Michal Szczepek Dennis Kwiatkowski David Speck Lucia Soletto José Miguel Cerdá-Reverter Heiko Krude Peter Kühnen Heike Biebermann Patrick Scheerer |
author_sort |
Nicolas Heyder |
title |
Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective |
title_short |
Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective |
title_full |
Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective |
title_fullStr |
Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective |
title_full_unstemmed |
Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective |
title_sort |
signal transduction and pathogenic modifications at the melanocortin-4 receptor: a structural perspective |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Endocrinology |
issn |
1664-2392 |
publishDate |
2019-07-01 |
description |
The melanocortin-4 receptor (MC4R) can be endogenously activated by binding of melanocyte-stimulating hormones (MSH), which mediates anorexigenic effects. In contrast, the agouti-related peptide (AgRP) acts as an endogenous inverse agonist and suppresses ligand-independent basal signaling activity (orexigenic effects). Binding of ligands to MC4R leads to the activation of different G-protein subtypes or arrestin and concomitant signaling pathways. This receptor is a key protein in the hypothalamic regulation of food intake and energy expenditure and naturally-occurring inactivating MC4R variants are the most frequent cause of monogenic obesity. In general, obesity is a growing problem on a global scale and is of social, medical, and economic relevance. A significant goal is to develop optimized pharmacological tools targeting MC4R without adverse effects. To date, this has not been achieved because of inter alia non-selective ligands across the five functionally different MCR subtypes (MC1-5R). This motivates further investigation of (i) the three-dimensional MC4R structure, (ii) binding mechanisms of various ligands, and (iii) the molecular transfer process of signal transduction, with the aim of understanding how structural features are linked with functional-physiological aspects. Unfortunately, experimentally elucidated structural information is not yet available for the MC receptors, a group of class A G-protein coupled receptors (GPCRs). We, therefore, generated MC4R homology models and complexes with interacting partners to describe approximate structural properties associated with signaling mechanisms. In addition, molecular insights from pathogenic mutations were incorporated to discriminate more precisely their individual malfunction of the signal transfer mechanism. |
topic |
G-protein coupled receptor melanocortin receptors MC4R MSH AgRP ACTH |
url |
https://www.frontiersin.org/article/10.3389/fendo.2019.00515/full |
work_keys_str_mv |
AT nicolasheyder signaltransductionandpathogenicmodificationsatthemelanocortin4receptorastructuralperspective AT gunnarkleinau signaltransductionandpathogenicmodificationsatthemelanocortin4receptorastructuralperspective AT michalszczepek signaltransductionandpathogenicmodificationsatthemelanocortin4receptorastructuralperspective AT denniskwiatkowski signaltransductionandpathogenicmodificationsatthemelanocortin4receptorastructuralperspective AT davidspeck signaltransductionandpathogenicmodificationsatthemelanocortin4receptorastructuralperspective AT luciasoletto signaltransductionandpathogenicmodificationsatthemelanocortin4receptorastructuralperspective AT josemiguelcerdareverter signaltransductionandpathogenicmodificationsatthemelanocortin4receptorastructuralperspective AT heikokrude signaltransductionandpathogenicmodificationsatthemelanocortin4receptorastructuralperspective AT peterkuhnen signaltransductionandpathogenicmodificationsatthemelanocortin4receptorastructuralperspective AT heikebiebermann signaltransductionandpathogenicmodificationsatthemelanocortin4receptorastructuralperspective AT patrickscheerer signaltransductionandpathogenicmodificationsatthemelanocortin4receptorastructuralperspective |
_version_ |
1724868603209056256 |
spelling |
doaj-c6f24ae870f145b8a2c9a641fa877eeb2020-11-25T02:20:57ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922019-07-011010.3389/fendo.2019.00515459031Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural PerspectiveNicolas Heyder0Gunnar Kleinau1Michal Szczepek2Dennis Kwiatkowski3David Speck4Lucia Soletto5José Miguel Cerdá-Reverter6Heiko Krude7Peter Kühnen8Heike Biebermann9Patrick Scheerer10Group Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, GermanyGroup Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, GermanyGroup Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, GermanyGroup Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, GermanyGroup Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, GermanyDepartamento de Fisiología de Peces y Biotecnología, Consejo Superior de Investigaciones Científicas, Instituto de Acuicultura Torre de la Sal, Ribera de Cabanes, SpainDepartamento de Fisiología de Peces y Biotecnología, Consejo Superior de Investigaciones Científicas, Instituto de Acuicultura Torre de la Sal, Ribera de Cabanes, SpainInstitute of Experimental Pediatric Endocrinology, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, GermanyInstitute of Experimental Pediatric Endocrinology, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, GermanyInstitute of Experimental Pediatric Endocrinology, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, GermanyGroup Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, GermanyThe melanocortin-4 receptor (MC4R) can be endogenously activated by binding of melanocyte-stimulating hormones (MSH), which mediates anorexigenic effects. In contrast, the agouti-related peptide (AgRP) acts as an endogenous inverse agonist and suppresses ligand-independent basal signaling activity (orexigenic effects). Binding of ligands to MC4R leads to the activation of different G-protein subtypes or arrestin and concomitant signaling pathways. This receptor is a key protein in the hypothalamic regulation of food intake and energy expenditure and naturally-occurring inactivating MC4R variants are the most frequent cause of monogenic obesity. In general, obesity is a growing problem on a global scale and is of social, medical, and economic relevance. A significant goal is to develop optimized pharmacological tools targeting MC4R without adverse effects. To date, this has not been achieved because of inter alia non-selective ligands across the five functionally different MCR subtypes (MC1-5R). This motivates further investigation of (i) the three-dimensional MC4R structure, (ii) binding mechanisms of various ligands, and (iii) the molecular transfer process of signal transduction, with the aim of understanding how structural features are linked with functional-physiological aspects. Unfortunately, experimentally elucidated structural information is not yet available for the MC receptors, a group of class A G-protein coupled receptors (GPCRs). We, therefore, generated MC4R homology models and complexes with interacting partners to describe approximate structural properties associated with signaling mechanisms. In addition, molecular insights from pathogenic mutations were incorporated to discriminate more precisely their individual malfunction of the signal transfer mechanism.https://www.frontiersin.org/article/10.3389/fendo.2019.00515/fullG-protein coupled receptormelanocortin receptorsMC4RMSHAgRPACTH |